Rosiglitazone (Avandia) and pioglitazone (Actos) and heart failure

Wooltorton, Eric
January 2002
CMAJ: Canadian Medical Association Journal;1/22/2002, Vol. 166 Issue 2, p219
Academic Journal
Reports that Health Canada has issued an advisory on November 30, 2001 after receiving an increasing number of reports of congestive heart failure (CHF), pulmonary edema, and pleural effusion suspected to be associated with the diabetic agents rosiglitazone and pioglitazone. Role of the Canadian Adverse Reaction Monitoring Program; Uses of the drugs in adult patients with type 2 diabetes mellitus and in patients with polycystic ovary syndrome.


Related Articles

  • TZDs linked with increased risk for heart problems, death. Haigh, Christen // Endocrine Today;1/10/2008, Vol. 6 Issue 1, p8 

    This article discusses research being done on the side effects of rosiglitazone in patients with diabetes. It references a study by L. L. Lipscombe et al., published in a 2007 issue of the "Journal of the American Medical Association." The study found that rosiglitazone was linked to an...

  • Carvedilol + enalapril well tolerated in mild congestive heart failure.  // Reactions Weekly;6/26/2004, Issue 1007, p6 

    Discusses research being done on the effect of the combination of carvedilol and enalapril on congestive heart failure. Reference to a study by M. Komajda et al., published in the June 2004 issue of the "European Journal of Heart Failure"; Parameters evaluated in the study; Frequency of...

  • TZDs linked to adverse CV outcomes in older DM patients.  // Reactions Weekly;1/5/2008, Issue 1183, p3 

    This article reports that researchers from the Institute for Clinical Evaluative Sciences in Canada has found that thiazolidinedione given in elderly patients with diabetes mellitus are more likely to experience congestive heart failure or myocardial infarction, thereby increasing the...

  • Cibenzoline.  // Reactions Weekly;9/25/2010, Issue 1320, p17 

    The article describes a case of fatal congestive heart failure in a 46-year-old man who received cibenzoline for paroxysmal atrial fibrillation.

  • Sunitinib.  // Reactions Weekly;2/20/2010, Issue 1289, p38 

    The article describes the case of two patients who acquired congestive heart failure (CHF) while undergoing treatment with sunitinib.

  • Inositol safety: clinical evidences. CARLOMAGNO, G.; UNFER, V . // European Review for Medical & Pharmacological Sciences;2011, Vol. 15 Issue 8, p931 

    Myo-inositol is a six carbon cyclitol that contains five equatorial and one axial hydroxyl groups. Myo-inositol has been classified as an insulin sensitizing agent and it is commonly used in the treatment of the Polycystic Ovary Syndrome (PCOS). However, despite its wide clinical use, there is...

  • Choriogonadotropin-α/follitropin-β/ leuprorelin.  // Reactions Weekly;7/26/2008, Issue 1212, p12 

    A case study involving a 37-year-old woman with polycystic ovary syndrome and infertility who developed ovarian hyperstimulation syndrome (OHSS) after receiving ovarian hyperstimulation treatment with choriogonadotropin-α, follitropin-Β and leuprorelin is presented. The clinical history...

  • Clomifene.  // Reactions Weekly;8/8/2009, Issue 1264, p13 

    The article describes the case of a 29-year-old woman who developed severe hypertriglyceridaemia during fertility treatment with clomifene. The patient had a history of polycystic ovary syndrome treated with metformin as well as a family history of hypertriglyceridaemia. She started receiving...

  • The metabolic effects of drugs used for the treatment of polycystic ovary syndrome. Karaköse, Melia; Çakal, Erman; Ertan, Kubilay; Delibaşı, Tuncay // Journal of the Turkish-German Gynecological Association;Sep2013, Vol. 14 Issue 3, p168 

    Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among women of reproductive age. It is characterized by menstrual disorders, hyperandrogenism (clinical and/or biochemical) and ultrasonographic features. It is well known that PCOS has unfavourable effects on carbohydrate...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics